Complement and microglia mediate early synapse loss in Alzheimer mouse models
Open accessThe DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index; 21 of the 28 sources its claims cite were checked for support.
Abstract
Too much cleaning up: The complement system and microglia seek out and destroy unwanted cellular debris for the peripheral immune system as well as excess synapses in the developing brain. Hong et al. now show how the system may go haywire in adults early in the progression toward Alzheimer's disease (AD). Aberrant synapse loss is an early feature of Alzheimer's and correlates with cognitive decline. In mice susceptible to AD, complement was associated with synapses, and microglial function was required for synapse loss. The authors speculate that aberrant activation of this “trash disposal” system underlies AD pathology. Science , this issue p. 712
Overview
CoChat Summary
TL;DR
In Alzheimer mouse models, classical complement proteins C1q and C3 increase and localize to synapses before plaques, and blocking C1q, C3, or microglial CR3 reduces early synapse loss. Soluble Aβ oligomers drive microglial engulfment of synaptic material through a CR3-dependent pathway, suggesting reactivation of developmental synaptic pruning in early AD.
Key findings
- J20 hAPP mice showed significant hippocampal synapse loss at 3–4 months, before plaque deposition; loss occurred in CA1, CA3, and dentate gyrus at 3 months but not in striatum, and was not seen at 1 month.
- C1q was elevated in J20 brains as early as 1 month, region-specifically in hippocampus and frontal cortex, and colocalized with PSD95-positive puncta; Compound E reduced soluble Aβ and C1q deposition, while oligomeric Aβ—but not monomeric Aβ or vehicle—induced C1q deposition and synaptic colocalization.
- Oligomeric Aβ induced synapse loss within 72 h in WT mice but not in C1qa knockout mice; anti-C1q antibody ANX-M1 prevented oAβ-induced synapse loss and LTP impairment, and APP/PS1xC3 KO mice did not show the synapse loss seen in 4-month APP/PS1 hippocampus.
- Microglial CD68 increased in J20 hippocampus and after oAβ; oAβ increased internalized Homer-GFP in microglia, failed to do so in CR3 KO mice, and induced hippocampal synapse loss in WT but not CR3 KO mice.
Methods
- Mouse models included J20 hAPP, APP/PS1, C1qa KO, C3 KO, CR3 KO, and Homer-GFP mice, with WT littermates and ages including 1 month, 3–4 months, and P21.
- Synapse quantification used super-resolution structured illumination microscopy, confocal imaging, and electron microscopy with colocalized pre- and postsynaptic puncta markers including synaptophysin/PSD95, synaptotagmin/homer, and synapsin/PSD95; C1q and C3 colocalization with PSD95 was also measured.
- Interventions included Compound E, intracerebroventricular or tail vein injections of soluble Aβ oligomers, monomers, or vehicle, anti-C1q antibody ANX-M1 or IgG control, acute hippocampal slice LTP recordings, and an in vivo synaptic engulfment assay.
Limitations
- The paper states that specific synaptic C1q receptors are not yet known and that oAβ and C1q may act indirectly through cytokines such as TGFβ, microglial or astrocytic activation, or other pathways including MHCI/PirB.
- The paper states that the complement pathway may not be involved in all pathological routes to AD, including plaque-associated synapse loss, and that future studies are needed to examine plaque-associated synapse loss and other synaptopathies such as tauopathies and Huntington’s disease.
- Evident from the text: the findings are from mouse models and acute hippocampal slices, not human AD tissue or clinical trials, and the study focuses on early pre-plaque mechanisms rather than established plaque-associated neuropathology.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
16 Valid · 0 Not valid · 2 Not checked · 48 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“C1q binds synapses in vulnerable regions undergoing synapse loss (our data here; (5, 27)).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [5] Stevens B The classical complement cascade mediates CNS synapse elimination. Cell 2007 131 1164 1178 18083105 source
The Results report C1q localized to synapses in the developing dLGN during synaptic pruning and relocalized to adult retinal synapses in early glaucoma, before significant synapse loss. The Discussion likewise places synaptic C1q relocalization before or concurrent with synapse loss in the glaucoma model. (LLM, conf=0.89)
- Not checked — no full text of the sourcecites [27] Stephan AH Barres BA Stevens B The complement system: an unexpected role in synaptic pruning during development and disease. Annu. Rev. Neurosci 2012 35 369 389 22715882 source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“suggesting that the engulfed synapses are internalized into lysosomal compartments in a manner similar to developmental synaptic pruning (6).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [6] Schafer DP Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner. Neuron 2012 74 691 705 22632727 PMC3528177 source
The Results section, “Microglia engulf RGC inputs during a period of active synaptic pruning” (page unavailable), reports that most engulfed RGC inputs colocalized with microglial lysosomal compartments. The Results section, “Microglia engulf presynaptic elements specific to RGCs” (page unavailable), also identifies an RGC presynaptic marker within microglial lysosomes, supporting the proposed similarity to developmental synaptic pruning. (LLM, conf=0.94)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Quantification of colocalized pre- and postsynaptic puncta (synaptophysin and PSD95 (Fig. 1A); synaptotagmin and homer (figs. S1A-D)) revealed a significant loss of synapses in J20 hippocampus at 3-4 months old (mo), an age that precedes plaque deposition (11, 12).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [11] Mucke L High-Level Neuronal Expression of Abeta 1-42 in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation. Journal of Neuroscience 2000 20 4050 10818140 PMC6772621 source
The citation is attached to the statement that 3–4 months precedes plaque deposition, not to the citing authors’ synapse measurements. In “Effects of hAPP mutations on formation of amyloid plaques” (Fig. 4; page not provided), the paper assesses mice at 2–4 months and reports amyloid deposition in APP Sw,Ind mice at 5–7 months; the paper identifies J20 as an APP Sw,Ind line. (LLM, conf=0.91)
- Supportedcites [12] Hong S Dynamic Analysis of Amyloid -Protein in Behaving Mice Reveals Opposing Changes in ISF versus Parenchymal A during Age-Related Plaque Formation. Journal of Neuroscience 2011 31 15861 15869 22049429 PMC3227224 source
The citation follows the statement that 3–4 months precedes plaque deposition, rather than the citing authors’ own synapse measurements. The Results section (page unavailable) identifies approximately 3-month-old J20 mice as pre-plaque and describes 3–7-month-old mice as plaque-free. (LLM, conf=0.91)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Genome-wide association studies (GWAS) implicate microglia and complement-related pathways in AD (1).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [1] Hong S Dissing-Olesen L Stevens B New insights on the role of microglia in synaptic pruning in health and disease. Curr Opin Neurobiol 2016 doi:10.1016/j.conb.2015.12.004 PMC5479435 26745839 source
The Introduction says GWAS and integrated network studies identify immune-related AD risk pathways implicating microglia. The section on microglia–synapse dysfunction identifies GWAS variants CLU and CR1, both related to complement. Page numbers are not provided in our copy. (LLM, conf=0.93)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“C1q was also similarly increased in hippocampus of another model of AD, the APP/PS1 mice (15) (Fig. S2C).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [15] Jankowsky JL Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum. Mol. Genet 2004 13 159 170 14645205 source
The citation identifies the APP/PS1 mouse model, while the citing document points to its own Fig. S2C for the C1q increase. Figure 2 (p. 4) describes APPswe/PS1 double-transgenic mice and shows hippocampal amyloid pathology in that model. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
48 more claims · 5 with their cited sources checked
Create a free account to see all 66 claims and every source verdict.
- It may state two separate claims as one. 11
- Probably not a substantial claim. 2
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“increasing evidence demonstrate that immune signaling may not just be a consequence of protein aggregation in the brain, but that it actually causes the buildup of aggregates at the earliest stages of the disease process.15–17”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [15]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In neurodegeneration, the complement pathway is activated, and inhibiting the complement proteins C1q or C3 results in less neuroinflammation, Aβ plaques and synapse loss29,30.”
From Exercise plasma boosts memory and dampens brain inflammation via clusterin (2021) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Before the onset of Aβ deposition, microglia engulf synapses opsonized with the complement factors C1q and C3 upon CR3-mediated recognition of C3 (121).”
From Microglia in Alzheimer's disease (2017) · cites this paper as [121]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Lack of C1q, C3, or CR3 curbed microglia activation and synaptic loss during amyloid plaque deposition.”
From Microglia Function in the Central Nervous System During Health and Neurodegeneration (2017) · cites this paper as [139]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Inappropriate control of the classical complement cascade causes unresolvable inflammation and disease (Hong et al. , 2016; Hansen, Hanson and Sheng, 2018; Morgan, 2018).”
From Spatial Transcriptomics and In Situ Sequencing to Study Alzheimer’s Disease (2020) · cites this paper as Hong et al., 2016
Experimental — accuracy not yet measured
70 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Self-check results appear here once an independent check has confirmed them.
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
In the paper
“It is also plausible that oAβ and C1q may work indirectly to mediate synapse loss through cytokines such as TGFβ (7), through microglial or astrocytic activation, or through other mechanisms including MHCI/PirB, another immune pathway critical for synapse elimination in development and AD (28-30).”
Cited work 10.1038/nn.3560 · retracted 2022-01-13 · notice 10.1038/s41593-021-00877-7 · this paper published 2016-05-06
Citations
Cites
1 retracted
Bialas, A. R., & Stevens, B. (2013) · Nature Neuroscience · doi:10.1038/nn.3560 · Cited by 519 · cited 2×
“It is also plausible that oAβ and C1q may work indirectly to mediate synapse loss through cytokines such as TGFβ (7), through microglial or astrocytic activation, or through other mechanisms including MHCI/PirB, another immune pathway critical for synapse elimination in development and AD (28-30).”
Self-citationRetractedAmyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420 · cited 1×
“Synaptic deficits occur in early AD and mild cognitively impaired patients before onset of plaques and are some of the first signs of the neuronal degenerative process (4, 23-25).”
Self-citationTerry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397 · cited 1×
“The degree of region-specific synapse loss is a stronger correlate of cognitive decline in AD than counts of plaques, tangles and neuronal loss (8, 9).”
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089
Self-citationThe Classical Complement Cascade Mediates CNS Synapse Elimination
Stevens, B., Allen, N. J., Vazquez, L. E., Howell, G. R., Christopherson, K. S., Nouri, N., Micheva, K. D., Mehalow, A. K., Huberman, A. D., Stafford, B., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.036 · Cited by 3,313 · cited 4×
“Although specific receptors for C1q at synapses are not yet known, C1q binds synapses in vulnerable regions undergoing synapse loss (our data here; (5, 27)).”
InfluentialSelf-citationIdentification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543 · cited 1×
“S11), indicating they are resident cells (22).”
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376 · cited 1×
“The degree of region-specific synapse loss is a stronger correlate of cognitive decline in AD than counts of plaques, tangles and neuronal loss (8, 9).”
Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856 · cited 3×
“S4), long before Aβ plaques deposit (11, 12), raising the question of whether C1q increase in these pre-plaque brains is dependent on soluble Aβ levels.”
Jankowsky, J. L., Fadale, D. J., Anderson, J., Xu, G. M., Gonzales, V., Jenkins, N. A., Copeland, N. G., Lee, M. K., Younkin, L. H., Wagner, S. L., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh019 · Cited by 1,575
Cited by
Items 2,201–2,300 of 3,349
Goal-Directed Action Is Initially Impaired in a hAPP-J20 Mouse Model of Alzheimer’s Disease
Dhungana, A., Becchi, S., Leake, J., Morris, G. P., Avgan, N., Balleine, B. W., Vissel, B., & Bradfield, L. A. (2023) · eNeuro · doi:10.1523/eneuro.0363-22.2023 · Cited by 8
“Second, IBA1 is a marker of all microglia, and it may be that only microglia that become activated as part of a (presumed) neuroinflammatory response differ according to the J20 genotype (Wright et al., 2013; Hong et al., 2016).”
BackgroundGong, Y., Luo, H., Li, Z., Feng, Y., Liu, Z., & Chang, J. (2023) · Metabolites · doi:10.3390/metabo13080954 · Cited by 7
“However, when excessive phagocytosis occurs, healthy synapses are “trimmed”, contributing to neurodegeneration [54].”
BackgroundCCR5 regulates Aβ1-42-induced learning and memory deficits in mice
Huang, H.-Y., Salinas, S., Cornell, J. L., Udoh, I.-B., Shen, Y., & Zhou, M. (2024) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2024.107890 · Cited by 7
Weng, W., Fu, J., Fan, C., Wang, Y., & Zhang, J. (2024) · Molecular Neurobiology · doi:10.1007/s12035-023-03907-6 · Cited by 7
“The result is consistent with experimental studies that synapse dysfunction is related to AD etiology [40].”
The role of the gut microbiome in the regulation of astrocytes in Alzheimer's disease
Chandra, S., & Vassar, R. J. (2024) · Neurotherapeutics · doi:10.1016/j.neurot.2024.e00425 · Cited by 7
Recognition protein C1q of innate immunity agglutinates nanodiamonds without activating complement
Bélime, A., Thielens, N. M., Gravel, E., Frachet, P., Ancelet, S., Tacnet‐Delorme, P., Caneiro, C., Chuprin, J., Gaboriaud, C., Schoehn, G., et al. (2018) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2018.09.009 · Cited by 8
Guo, X., Mao, R., Cui, L., Wang, F., Zhou, R., Wang, Y., Huang, J., Zhu, Y., Yao, Y., Zhao, G., et al. (2021) · General Psychiatry · doi:10.1136/gpsych-2020-100440 · Cited by 6
“11 Since microglia and neurons can send signals to one another, the abnormal communication between them might lead to neuronal apoptosis, 12 cognitive dysfunction 13 and poor treatment response.”
BackgroundLee, Y. F., Lariviere, L., Russ, A., Choi, S., Bacskai, B. J., & Kastanenka, K. V. (2021) · eNeuro · doi:10.1523/eneuro.0389-20.2021 · Cited by 6
“Nevertheless, astrocytes and microglia were reported to play an active role in Alzheimer’s progression (Hong et al., 2016; Kastanenka et al., 2020).”
BackgroundRiemann, S., Kolibabka, M., Busch, S., Lin, J., Hoffmann, S., Gretz, N., Feng, Y., Wohlfart, P., & Hammes, H. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.660164 · Cited by 6
TSPO PET Imaging as a Biomarker of Neuroinflammation in Neurodegenerative Disorders
Werry, E. L., Bright, F., & Kassiou, M. (2021) · Neuromethods · doi:10.1007/978-1-0716-1712-0_17 · Cited by 6
Wang, K., Jiang, Z., Yu, X., Shao, Y., Liu, H., Wu, S., Kong, L., & Wang, Z. (2022) · Medicine · doi:10.1097/md.0000000000028946 · Cited by 6
McGlasson, S. L., & Hunt, D. P. J. (2017) · Nature · doi:10.1038/nature23087 · Cited by 6
Kopec, A. M., Smith, C. J. W., Ayre, N. R., Sweat, S. C., & Bilbo, S. D. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/211029 · Cited by 6
Aksenova, M. V., Sybrandt, J., Cui, B., Sikirzhytski, V., Ji, H., Odhiambo, D. A., Lucius, M. D., Turner, J. R., Broude, E. V., Peña, E. A., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/591438 · Cited by 9
Salter, E. W., Lei, G., Choi, S.-L., Ralph, L. T., Zhang, L., Jin, F., Kadia, A., Wang, J., Georgiou, J., & Collingridge, G. L. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.20.106930 · Cited by 11
Cellular and molecular phenotypes of C9orf72 ALS/FTD patient derived iPSC-microglia mono-culturesPreprint
Lorenzini, I., Alsop, E. B., Levy, J., Gittings, L. M., Lall, D., Rabichow, B. E., Moore, S. R., Pevey, R. S., Bustos, L. M., Burciu, C., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.09.03.277459 · Cited by 6
“However, synaptic pruning pathways are known to be re-activated in neurodegeneration 6 leading to synapse loss and contributing to cognitive impairments (101-104).”
BackgroundTakuwa, H., Orihara, A., Takado, Y., Urushihata, T., Shimojo, M., Ishikawa, A., Takahashi, M., Barron, A. M., Ono, M., Maeda, J., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.11.04.368977 · Cited by 6
Evidence for trans-synaptic propagation of oligomeric tau in Progressive Supranuclear PalsyPreprint
McGeachan, R. I., Keavey, L., Rose, J. L., Simzer, E. M., Chang, Y. Y., Spires-Jones, M. P., Gilmore, M., Ravingerova, N., Scutariu, C., Taylor, L. W., et al. (2022) · medRxiv · doi:10.1101/2022.09.20.22280086 · Cited by 5
Caramello, A., Fancy, N., Tournerie, C., Eklund, M., Chau, V., Adair, E., Papageorgopoulou, M., Jackson, J., Hardy, J., & Matthews, P. M. (2023) · medRxiv · doi:10.1101/2023.11.23.23298911 · Cited by 3
TIA1 Mediates Divergent Inflammatory Responses to Tauopathy in Microglia and MacrophagesPreprint
Webber, C. J., van der Spek, S. J. F., Cruz, A. L., Puri, S., Zhang, C., Aw, J. T. M., Papadimitriou, G.-Z., Roberts, R., Jiang, K., Tran, T., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.06.622325 · Cited by 7
Tapella, L., Dematteis, G., Vitola, P. L., Leva, S., Tonelli, E., Raddi, M., Delconti, M., Dacomo, L., Macchia, A. L., Murari, E., et al. (2024) · Glia · doi:10.1002/glia.24509 · Cited by 5
“…in indACNKO-AD mice, because of the strong association described between glial activation, neuroinflammation, and synaptic plasticity and memory (Al-Onaizi et al., 2022; Amirahmadi et al., 2022; Balducci et al., 2017; Hong et al., 2016; Morris et al., 2013; Sandhu et al., 2022; Zhang et al., 2022).”
BackgroundMicroglia‐Mediated Synaptic Dysfunction Contributes to Chemotherapy‐Related Cognitive Impairment
Wang, J., Zhang, H., Augenreich, M. A., Luis Martinez‐Lemus, A., Liu, Z., Kang, X., Lu, B., Chang, H., Yeh, E. T. H., Cata, J. P., et al. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70024 · Cited by 8
“In disease states such as Alzheimer's disease and Parkinson's disease, microglia are involved in aberrantly increased synaptic pruning (Hong et al. 2016).”
Neuroglia in anxiety disorders
Bonomi, R. E., Pietrzak, R. H., & Cosgrove, K. (2025) · Handbook of clinical neurology · doi:10.1016/b978-0-443-19102-2.00008-9 · Cited by 5
Ganglioside GT1b prevents selective spinal synapse removal following peripheral nerve injury
Lee, J., Noh, K., Lee, S., Kim, K. H., Chung, S., Lim, H., Hwang, M., Lee, J.-H., Chung, W., Chang, S., et al. (2025) · EMBO Reports · doi:10.1038/s44319-025-00452-2 · Cited by 4
“Disruptions in that balance can lead to aberrant synaptic loss or the preservation of unwanted synapses, both of which perpetuate pathological states (DeVries et al, 2024; Hong et al, 2016; Wilton et al, 2023).”
Pan, W., Teng, Y., Han, X., Liu, S., Pang, X., Wang, L., & Zhao, M. (2025) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2025.100193 · Cited by 8
“Previous research showed that in AD mouse models, the complement effector protein C1q can promote the activation of C3 (including C3a and C3b) and microglia, leading to the release of inflammatory factors and cytotoxins and the damage of neurons and synapses, resulting in synapse losses [ 107 ].”
Dysregulations of C1QA, C1QB, C1QC and C5AR1 as candidate biomarkers of vascular dementia
Xu, Y., Zhang, H., Jiao, X., Zhang, Y., Yin, G., Wang, C., Du, Z., Liang, M., Gao, X., Gu, Z., et al. (2025) · npj Aging · doi:10.1038/s41514-025-00228-x · Cited by 8
“Complement receptors are also expressed by inap-propriately activated microglia, and they play a detrimental role in normal aging and neurodegenerative pathology 40 – 42 .”
Reactive Astrocytes with Reduced Function of Glutamate Transporters in the App NL-G-F Knock-in Mice
Srivastava, I., Goikolea, J., Kaya, T. A., Latorre‐Leal, M., Eroli, F., Iglesias, M. P., Álvarez-Jiménez, L., Arroyo‐García, L. E., Shimozawa, M., Nilsson, P., et al. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00714 · Cited by 10
Microglia eliminate inhibitory synapses and drive neuronal hyperexcitability in epilepsy
(2025) · Nature Neuroscience · doi:10.1038/s41593-025-01983-6 · Cited by 6
Basak, J. M., Falk, M., Dingman, A., Moore, A., Tiemeier, E., Aimale, G., & Quillinan, N. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115364 · Cited by 6
Innate Immune Mechanisms in the Central Nervous System
Shastri, A., Yasmin, H., & Kishore, U. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-85340-1_15 · Cited by 4
Lai, W., Chen, J., Zhu, H., Jiang, Y., Niu, Y., Chen, Q., Luo, Z., Hu, Y., Li, F., Wang, Y., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116012 · Cited by 7
Redox modulation of the complement cascade contributes to synapse loss in Alzheimer's disease
Oh, C.-K., Wang, Y., & Lipton, S. A. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2025.e00707 · Cited by 8
“In these studies, synapse elimination occurred through micro-glial ingestion via the complement receptor, CR3 (the receptor for C3b) [17,21].”
InfluentialCognitive loss after brain trauma results from sex-specific activation of synaptic pruning processes
Arizanovska, D., Bush, G., Dallera, C. A., Folorunso, O. O., Frye, J. B., Doyle, K. P., Jagid, J. R., Wolosker, H., de Mônaco, B. A., Cordeiro, J. G., et al. (2025) · Brain · doi:10.1093/brain/awaf293 · Cited by 8
Su, W.-S., Wu, M.-T., Cheng, I. H.-J., & Yang, F. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115420 · Cited by 5
From synaptic dynamics to cognitive decline: Molecular insights into neuroplasticity
C, B. K., & G., P. P. C. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123937 · Cited by 13
Xu, Y., Han, T., Wu, Y., Liu, H., Hou, K., An, Z., Li, Y., Zhu, C., Wang, S., & Wei, J. (2025) · Neuroscience Bulletin · doi:10.1007/s12264-025-01505-1 · Cited by 5
“A1 astrocytes contribute to this process by releasing additional inflammatory mediators, such as complement C3 and various cytokines [237].”
Ying, C., & Lin, F. (2025) · NeuroImmunoModulation · doi:10.1159/000548491 · Cited by 6
“Activated microglia engage in aberrant synaptic pruning via complement-mediated mechanisms, contributing to hippocampal synaptic loss observed in patients with POCD [13].”
Zhang, N., Tian, T., Wang, Z., He, X., Cao, W., Zhang, W., Xing, Y., & Yang, N. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1671204 · Cited by 7
Differential selectivity of microglia and astrocytes in HIV-1 gp120-induced synaptic pruning
Watson, Z. T., Valdebenito-Silva, S., Spurgat, M. S., Ru, W., Zheng, J., Maurelli, M. K., Liang, Y., Yuan, S., Eugenín, E. A., & Tang, S. (2025) · Brain · doi:10.1093/brain/awaf429 · Cited by 5
Dual role of complement in neuronal repair
Łukomska, A., Ciesielski, P., Ratajczak, M. Z., & Kucia, M. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1712452 · Cited by 6
“This process drives early synapse loss, a key correlate of cognitive decline in AD (53).”
Evolving insights into the identity and function of dark microglia
Flury, A., St-Pierre, M.-K., Ayata, P., & Tremblay, M.-È. (2026) · Trends in Neurosciences · doi:10.1016/j.tins.2025.11.002 · Cited by 8
Gallo, C., Verrillo, L., Manzo, E., Cauzzi, E., Barbera, L. L., Sabatino, G., Paolis, M. L. D., Sciacca, M. F. M., Barra, G., Peroni, E., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03634-w · Cited by 10
“Indeed, at the cellular level, SULF A enhances the phagocytosis of multiple Aβ species, with a pronounced effect also on soluble oligomers, which are more neurotoxic and resistant to clearance by quiescent microglia [71].”
Liu, J., Hou, L., Ma, Y., Tian, L., Hong, J.-S., Zhao, J., & Wang, Q. (2026) · Redox Biology · doi:10.1016/j.redox.2026.104062 · Cited by 13
Ba, J., Brenna, C. T. A., Kaustov, L., Wang, D.-S., & Orser, B. A. (2026) · British Journal of Anaesthesia · doi:10.1016/j.bja.2026.01.004 · Cited by 6
“Both changes have been observed in models of inflammation 112 — 115 and surgery.”
Neuroimmune dysregulation in Alzheimer's disease: Mechanisms and therapeutic strategies
He, H., Zhu, S., Zhang, C., Wang, H., Li, Y., & Qian, H. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103055 · Cited by 11
Li, Z., Tan, B., Dong, K., Yu, X., Zhang, S. W., Luo, L., Yao, W., Qin, Z., & Wu, F. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.117779 · Cited by 6
Wang, Y., Qi, H., Dong, W., Chen, Y., Nisubire, D., Zeng, Y., & Li, J. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03746-x · Cited by 6
Endogenous retrovirus-derived RNA-DNA hybrids induce microglial synaptic pruning in autism models
Chen, S., Zhang, B., Qin, T., Zhu, M., Chen, Q., Lu, X., Pan, H., Yang, Q., Guo, S., Gong, R., et al. (2026) · Neuron · doi:10.1016/j.neuron.2026.01.011 · Cited by 8
Cai, L., Zhang, Y., Li, J., Hu, L., Meng, Q., Shao, J., Deng, H., Liu, Y., Liu, J., Liang, Y., et al. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08557-9 · Cited by 6
“Within the complement cascade, C3 plays a central role in initiating downstream signaling and localizes on synapses, mediating microglia-dependent engulfment of synapses through CR3 receptors, which are exclusively expressed on microglia [25, 29, 33].”
Glial dynamics in brain aging: Cellular heterogeneity and regional vulnerability
Suk, K. (2026) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2026.102915 · Cited by 6
Glial Contributions to Lafora Disease: A Systematic Review
Vecchia, S. D., Marchese, M., & Santorelli, F. M. (2022) · Biomedicines · doi:10.3390/biomedicines10123103 · Cited by 6
Connolly, K. J., Margaria, J., Biase, E. D., Cooper, O., Hallett, P. J., & Isacson, O. (2023) · Cells · doi:10.3390/cells12212564 · Cited by 8
“Increased C1q levels in the hippocampus of AD brains and experimental models are associated with increased synapse elimination by microglial phagocytosis [49,50].”
BackgroundZhou, J., Wang, Z., Sun, Y., Fu, Y., Li, D., Tan, L., & Initiative, A. D. N. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230513 · Cited by 6
Erol, A. Y. G., Koçancı, F. G., Akıncı, E., Dora, D. D., Erendor, F., Şanlıoğlu, S., & Uysal, H. (2024) · European Journal of Neuroscience · doi:10.1111/ejn.16273 · Cited by 7
“Clearly, microglial cells play active roles in the pathogenesis of PD, as well as AD, multiple sclerosis and autism (Block et al., 2007; Goldmann & Prinz, 2013; Hong et al., 2016; Qian & Flood, 2008; Ransohoff & Perry, 2009; Takano, 2015; Zhan et al., 2014).”
BackgroundQin, H., Shi, X., Zhu, Y., Ma, J., Xiaohong, D., & Wang, L. (2024) · European Journal of Neuroscience · doi:10.1111/ejn.16392 · Cited by 6
Intracellular C1q—an unexpected player in neuronal proteostasis
West, E. E., & Kemper, C. (2024) · Trends in Immunology · doi:10.1016/j.it.2024.09.006 · Cited by 5
Emerging Roles for MFG‐E8 in Synapse Elimination
Aviani, M. G., & Ménard, F. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70009 · Cited by 5
“…of live synapses and axons: complement receptor 3 (CR3), triggering receptor expressed on myeloid cells 2 (TREM2), and G-protein coupled receptor 56 (GPR56) (Filipello et al. 2018; Hong et al. 2016; T. Li et al. 2020; Lim and Ruthazer 2021; Schafer et al. 2012; Scott-Hewitt et al. 2020).”
Liu, Y., Chen, R., Mu, C., Diao, J., Guo, Y., Yao, X., Shi, S., Wang, M., Zhang, Z., Qin, X., et al. (2025) · Aging Cell · doi:10.1111/acel.70003 · Cited by 8
“C1q acts as the initiator in the classical complement cascade, playing a pivotal role in guiding microglia toward the early phagocytosis of synapses (Hong et al. 2016).”
Chen, Y., Yao, X., Wang, C., Zhuang, H., Xie, B., Sun, C., Wang, Z., Zhou, X., Luo, Y., Zhang, Y., et al. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.03.035 · Cited by 5
Zhu, S., Wang, N., Chen, S., Zou, J., & Tan, S. (2025) · Neurochemistry International · doi:10.1016/j.neuint.2025.106014 · Cited by 8
Zheng, Y., Ma, L., Wang, Y., Huang, J., Ye, J., & Yang, X. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.5c02188 · Cited by 5
Thelagathoti, R. K., Tom, W. A., Chandel, D. S., Jiang, C. Q., Krzyzanowski, G. D., Olou, A. A., & Fernando, M. R. (2025) · Biomolecules · doi:10.3390/biom15070963 · Cited by 7
Arndt, P., Morton, L., Briese, M., Lämmlin, N., Mattern, H., Hasanuzzaman, M., Westhues, M., Khoshneviszadeh, M., Appenzeller, S., Gündel, D., et al. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.125.040710 · Cited by 9
Roles of glia-derived extracellular vesicles in central nervous system diseases: an update
Sun, H., Su, X., Li, S., Mu, D., & Qu, Y. (2021) · Reviews in the Neurosciences · doi:10.1515/revneuro-2020-0144 · Cited by 5
Self-citationGannon, M. A., Wang, B., Stringfellow, S. A., Quintin, S. S., Mendoza, I., Srikantha, T., Roberts, A. C., Saito, T., Saido, T. C., Roberson, E. D., et al. (2022) · eNeuro · doi:10.1523/eneuro.0368-21.2022 · Cited by 5
“Golgi staining or super-resolution structured illumination microscopy would have been a more sensitive approach for measuring synapse loss (Hong et al., 2016).”
BackgroundApplications of single‐cell multi‐omics sequencing in deep understanding of brain diseases
Zhang, X., Lü, P., & Shen, X. (2022) · Clinical and Translational Discovery · doi:10.1002/ctd2.95 · Cited by 6
Muza, P. M., Bush, D., Pérez-González, M., Zouhair, I., Cleverley, K., Llorian, M., Aoidi, R., West, S. J., Good, M. A., Tybulewicz, V. L. J., et al. (2023) · iScience · doi:10.1016/j.isci.2023.106073 · Cited by 7
Gaber, A. M., El-Bakry, A. M., Aljàrari, R. M., Jaber, F. A., Khadrawy, Y. A., Sabry, D., Abo‐Eleneen, R. E., & Ahmed, O. M. (2023) · Stem Cells International · doi:10.1155/2023/2690949 · Cited by 7
“Moreover, Aβ-induced microglial activation and downstream inflammatory responses further accelerate Aβ deposition [55], resulting in a self-sustaining neurogenerative condition.”
BackgroundJin, B., Fei, G., Sang, S., & Zhong, C. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1152279 · Cited by 5
APP family member dimeric complexes are formed predominantly in synaptic compartments
Schilling, S., August, A., Meleux, M., Conradt, C., Tremmel, L. M., Teigler, S., Adam, V., Müller, U., Koo, E. H., Kins, S., et al. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01092-6 · Cited by 8
“J20 mice show the highest APP expression in the neocortex and hippocampus [44] and amyloid plaques are observed at 5–7 months in the dentate gyrus and neocortex in this AD mouse model [42, 44].”
BackgroundIzquierdo, P., Jolivet, R., Attwell, D., & Madry, C. (2023) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-023-02871-3 · Cited by 9
“As similar mechanisms are thought to occur during brain ageing and brain disease [3, 16, 28, 65, 67, 69], we also assessed whether the Ca 2+ activity of microglia was affected differently by AD and normal ageing.”
BackgroundHiding in plain sight: Do recruited dendritic cells surround amyloid plaques in Alzheimer’s disease?
Nelson, R. B., Rose, K. N., Menniti, F. S., & Zorn, S. H. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116258 · Cited by 6
The Role of Glial Cells in Neurobiology and Prion Neuropathology
Hay, A. J. D., Popichak, K. A., Moreno, J. A., & Zabel, M. D. (2024) · Cells · doi:10.3390/cells13100832 · Cited by 7
“The proteins involved in the complement cascade, namely C1q, C3, C4, and the C3 receptor on microglia, have been implicated in phagocytosis and over-pruning of synapses in mouse models of Alzheimer’s and other diseases [56,69].”
BackgroundLeng, F., Hinz, R., Gentleman, S., Dani, M., Brooks, D. J., & Edison, P. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-230442 · Cited by 5
Wang, E. Y., Chen, H. S., Wu, M.-C., Yang, Y. L., Wang, H.-L., Liu, C., & Lai, T. W. (2024) · PLoS ONE · doi:10.1371/journal.pone.0308464 · Cited by 6
Arndt, H., Bachurski, M., Yuanxiang, P., Franke, K., Wessjohann, L. A., Kreutz, M. R., & Grochowska, K. M. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04509-6 · Cited by 8
Yan, Q., Li, X., Wang, Q.-Q., Jia, W. P., & Wang, S. (2025) · Molecular Neurobiology · doi:10.1007/s12035-024-04673-9 · Cited by 5
“In previous studies, the aberrant expression of synaptophysin was found in patients and animal models of neurodegenerative and neuropsychiatric disorders [6, 7].”
Xie, Z., Li, L., Hou, W., Fan, Z., Zeng, L., He, L., Ji, Y., Zhang, J., Wang, F. J., Xing, Z., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06112-2 · Cited by 7
Mitchener, V. F. T., Thackray, M. J., & Arancibia‐Cárcamo, I. L. (2025) · The Journal of Physiology · doi:10.1113/jp287015 · Cited by 8
“Dysregulation of synapse elimination is a classic example of AD pathology, and it is likely that microglial regulation of this process is key to disease progression (Hong et al., 2016).”
Clark, D. O., Xu, H., Callahan, C. M., & Unverzagt, F. W. (2016) · Obesity · doi:10.1002/oby.21631 · Cited by 10
“Adults with obesity have elevated levels of circulating proinflammatory cytokines, and there is growing evidence that, over time, systemic inflammation leads to changes in brain structure and function (4,5).”
BackgroundHollingsworth, E. W., Khouri, J., & Imitola, J. (2017) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2017.1287564 · Cited by 5
‘Amytrapper’, a Novel Immobilized Sepharose API Matrix, Removes Amyloid-β from Circulation in vitro
Gandbhir, O., & Sundaram, P. (2019) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-180093 · Cited by 7
Prokaryotic SPHINX 1.8 REP protein is tissue‐specific and expressed in human germline cells
Manuelidis, L. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27907 · Cited by 8
Fang, M., Zhao, Y., & Liu, X. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.06.73 · Cited by 7
Intrinsic antiviral immunity drives neurodegeneration in Alzheimer disease
Pluchino, S., & Willis, C. M. (2020) · Journal of Clinical Investigation · doi:10.1172/jci135906 · Cited by 5
The Amyloid-beta rich CNS environment alters myeloid cell functionality independent of their origin
Drost, N., Houtman, J., Cseresnyés, Z., Niesner, R. A., Rinnenthal, J.-L., Miller, K. R., Prokop, S., & Heppner, F. L. (2020) · Scientific Reports · doi:10.1038/s41598-020-63989-3 · Cited by 5
Protecting Connections from Synapse Elimination
Sell, G. L., & McAllister, A. K. (2020) · Trends in Neurosciences · doi:10.1016/j.tins.2020.08.005 · Cited by 5
Advances in microglia cellular models: focus on extracellular vesicle production
Ceccarelli, L., Marchetti, L., Giacomelli, C., & Martini, C. (2021) · Biochemical Society Transactions · doi:10.1042/bst20210203 · Cited by 6
Choi, Y. J., Song, H. J., Kim, J. E., Lee, S. J., Jin, Y. J., Roh, Y. J., Seol, A., Kim, H. S., & Hwang, D. Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126862 · Cited by 8
“The synaptic loss and neuronal loss, as well as microglial activation, are positively correlated with increased levels of C3 and C3aR expression [11,12].”
BackgroundGarcia, M. G., Paulus, A., Vázquez‐Reyes, S., Klementieva, O. L., Gouras, G. K., Bachiller, S., & Deierborg, T. (2023) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2023.100663 · Cited by 8
Wang, J., Joseph, S., Vingill, S., Dere, E., Tatenhorst, L., Ronnenberg, A., Lingor, P., Preisinger, C., Ehrenreich, H., Schulz, J. B., et al. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15962 · Cited by 4
Lima‐Filho, R. A. S., & Oliveira, M. M. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.3307-17.2018 · Cited by 5
“The interaction between PrP C and mGluR5 has previously been shown to play a key role in the persistence of LTD in AD models (Hu et al., 2014).”
BackgroundAstrocytes in Pathogenesis of Multiple Sclerosis and Potential Translation into Clinic
Izrael, M., Slutsky, S. G., & Michel, R. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.88261 · Cited by 5
Luo, T., & Gao, T. (2021) · Neuroscience Bulletin · doi:10.1007/s12264-021-00690-z · Cited by 5
“Overall, the phagocytic capacity of astrocytes appears to decrease during reactive astrogliosis [15, 16].”
BackgroundComplement Receptors in Myeloid Cell Adhesion and Phagocytosis
Dustin, M. L. (2017) · ASM Press eBooks · doi:10.1128/9781555819194.ch23 · Cited by 7
Magusali, N., Graham, A. C., Piers, T. M., Panichnantakul, P., Yaman, Ü., Shoai, M., Reynolds, R. H., Botía, J. A., Brookes, K. J., Guetta‐Baranes, T., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.16.435702 · Cited by 5
“These DAM or ARM cells are thought to regulate complement-dependent phagocytosis of synapses, which may be dependent on phospholipid signals presented on damaged cell membranes (Edwards, 2019; Györffy et al., 2018; Hardy and Escott-Price, 2019; Hong et al., 2016; Scott-Hewitt et al., 2020).”
BackgroundWilton, D. K., Mastro, K. J., Heller, M. D., Gergits, F. W., Willing, C. R., Frouin, A., Daggett, A., Gu, X., Kim, A. Y., Faull, R. L. M., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.03.471180 · Cited by 5
Self-citationPerivascular SPP1 Mediates Microglial Engulfment of Synapses in Alzheimer’s Disease ModelsPreprint
Schepper, S. D., Ge, J. Z., Crowley, G., Ferreira, L. S. S., Garceau, D. T., Toomey, C. E., Sokolova, D., Childs, T., Lashley, T., Burden, J. J., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.04.04.486547 · Cited by 5
“3A)(12), which allows to monitor microglia- and complement-mediated synapse engulfment in contralateral hippocampus of WT mice post intracerebroventricular (ICV) injection of oAβ [Aβ (1-40) S26C dimers].”
MethodSelf-citationHenstridge, C. M., & Spires‐Jones, T. L. (2018) · doi:10.26226/morressier.5b31ec442afeeb001345a7e4 · Cited by 6
Zhang, G., Xia, S., Zhang, N. K., Gao, F., Zloković, B. V., Zhang, L. I., Zhao, Z., & Tao, H. W. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.07.539389 · Cited by 5
“…Marta Olah et al. 2020; Blue B. Lake et al. 2016; Jorge L. Del-Aguila et al. 2019), as well as in animal models such as the 5xFAD (Yaming Wang et al. 2016; Habib et al. 2020; Minghui Wang et al. 2022) and APP/PS1 mice (Minghui Wang et al. 2022; Emma Gerrits et al. 2021; Soyon Hong et al. 2016).”
Metadata
- Authors
- Hong, S., Beja-Glasser, V. F., Nfonoyim, B. M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K. M., Shi, Q., Rosenthal, A., Barres, B. A., Lemere, C. A., Selkoe, D. J., & Stevens, B.
- Affiliations
- Boston Children's Hospital (US)
- Brigham and Women's Hospital (US)
- University of California, San Francisco (US)
- Stanford Medicine (US)
- Broad Institute (US)
- Corresponding author
- Beja-Glasser, Victoria F.
- Nfonoyim, Bianca M.
- Stevens, Beth
- ORCID
- Venue
- Science
- Published
- 2016-05-06
- Volume
- 352
- Issue
- 6286
- Pages
- 712-716
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC5094372
- OpenAlex
- W2314634699
- Cited by
- 3,343
- References
- 33
- Citations by year
- 2026: 415 · 2025: 391 · 2024: 384 · 2023: 388 · 2022: 324 · 2021: 363 · 2020: 306 · 2019: 260 · 2018: 240 · 2017: 198 · 2016: 69
- FWCI
- 140.04
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Edward R. and Anne G. Lefler Fellowship
- Coins for Alzheimer's Research Trust
- Fidelity Biosciences Research Initiative
- JPB Foundation
- National Institutes of Health (AG000222)
- National Institute of Neurological Disorders and Stroke-NIH (R01NS083845)
- National Institute on Aging-NIH (1RF1AG051496A)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- Alzheimer's disease, synaptic loss, complement system, microglia, C1q, CR3, complement C3, soluble amyloid-beta oligomers, neuroinflammation, synaptic pruning, hippocampal long-term potentiation, phagocytosis, mouse model
- MeSH terms
- Disks Large Homolog 4 Protein, Alzheimer Disease, Animals, Cognition Disorders, Complement Pathway, Classical, Disease Models, Animal, Membrane Proteins, Phagocytosis, Synapses, Up-Regulation, Complement C1q, Macrophage-1 Antigen, Amyloid beta-Peptides, Synaptophysin, Microglia, Long-Term Potentiation, Mice, Knockout, Mice, Guanylate Kinases, CA1 Region, Hippocampal, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.